Can a protocol be signed electronically?

Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. §7001) and UETA where adopted. Confirm any institutional or sponsor requirements for signer authentication and retainable audit trails to demonstrate intent and attribution.

Do patient consent forms require special disclosures?

Yes. For consumer-facing health documents, include an ESIGN consumer disclosure where required and ensure consent language meets HIPAA and IRB requirements for use and sharing of protected health information.

When is notarization required for protocol documents?

Notarization is rarely required for the protocol itself but may be required for certain legal agreements or authorization forms. Check institutional policies and state notary rules if a signature acknowledgement is requested.

How long must protocol records be retained?

Retention depends on regulatory and sponsor requirements: IRS records generally 3 years (IRC §6501(a)), HIPAA 6 years (45 CFR §164.530(j)), and some financial or SEC-related records longer. Follow sponsor and institutional policies.

What causes IRB review delays?

Common causes include incomplete documentation, unclear eligibility criteria, missing consent forms, inadequate safety monitoring plans, and inconsistent versioning. Address these items before submission to reduce turnaround time.

Can remote online notarization (RON) be used?

Many states permit RON, but rules vary. Verify state-specific RON availability and institutional acceptance, and retain required audio-video records and identity proofing per the state's notary standards.

Electronic Signature
Templates
Miscellaneous
Research Study Protocol

Research Study Protocol

This template is fully customizable. Edit the text, fill out the fields, and send it for signature. Give it a try!

RESEARCH STUDY PROTOCOL

Parties and Effective Date

This Research Study Protocol (the Protocol) is entered into by and between Sponsor: and Principal Investigator / Institution: .

Effective Date:

WHEREAS

WHEREAS, Sponsor has developed or funded an investigational study and requires a formal protocol to define objectives, methods, data handling, safety monitoring and reporting; and

WHEREAS, Principal Investigator and Institution possess the expertise, facilities and personnel necessary to conduct the Study in accordance with applicable laws, ethical standards and this Protocol; and

NOW, THEREFORE, the Parties set forth the Study objectives, procedures, responsibilities and terms in this Protocol.

Study Identification

Study Title Protocol Number

Scope of Work

Scope of Work (describe tasks, deliverables, milestones)

Study Objectives and Background

Primary and Secondary Objectives Background and Rationale

Methodology and Procedures

Study Design and Procedures Data Collection and Source Documents

Study Population

Inclusion Criteria Exclusion Criteria Sample Size and Power

Safety, Monitoring and Reporting

Adverse Event Reporting Monitoring and Audits

Data Management and Confidentiality

All study data collected pursuant to this Protocol shall be treated as confidential and handled in accordance with applicable data protection laws. Confidential Information includes participant data, study endpoints, unblinded results, and any non-public Sponsor materials. The Receiving Party shall implement administrative, physical and technical safeguards to protect Confidential Information.

Data Retention Period

Consent and Ethics

The Investigator shall obtain informed consent from each participant prior to performance of any study-specific procedures, using an IRB/ethics-committee approved consent form. Consent processes must include explanation of risks, benefits, alternatives and data handling, and must be documented in source records.

Payment Terms

Total Payment Amount Schedule of Payments Late Payment Fee

Term and Termination

This Protocol commences on Start Date: and continues until End Date: unless earlier terminated as provided herein.

Termination Notice Period Termination for Cause or Convenience

Confidentiality

Each party shall maintain as confidential all Confidential Information disclosed in connection with the Study and shall not use such information except to perform obligations under this Protocol. Confidentiality obligations survive termination for a period equal to the Data Retention Period specified above. Disclosure is permitted only to personnel who have a need to know and who are bound by confidentiality obligations no less protective than those herein. Required disclosures by law or court order shall be subject to prior notice to the disclosing party where permissible.

Publications and Ownership of Data

Publication Policy Ownership of Study Data and Intellectual Property

Amendments

Any amendment to this Protocol must be made in writing and signed by authorized representatives of both parties. Amendments affecting participant safety or consent must receive prior ethics committee approval before implementation.

Procedure for Amendments

Indemnification and Insurance

Indemnity Insurance Requirements

Governing Law and Dispute Resolution

This Protocol shall be governed by and construed in accordance with the laws of the State/Province of without regard to conflict-of-law principles. The parties shall attempt to resolve disputes in good faith through negotiation; if unresolved, disputes shall be submitted to binding arbitration in the jurisdiction specified above unless otherwise mutually agreed in writing.

Entire Agreement

This Protocol, together with any exhibits, schedules and mutually executed amendments, constitutes the entire agreement between the parties regarding the Study and supersedes all prior negotiations, proposals and communications, whether written or oral, relating to the Study.

Miscellaneous Provisions

If any provision of this Protocol is held invalid or unenforceable, the remaining provisions shall remain in full force and effect. Neither party may assign its rights or delegate its obligations under this Protocol without the prior written consent of the other party, except to an affiliated entity that agrees in writing to assume such obligations.

Sponsor Printed Name:

By:

Date:

Investigator / Institution Printed Name:

By:

Date:

What a Research Study Protocol Is

A Research Study Protocol is a formal written plan that describes the objectives, design, methodology, statistical considerations, and organization of a clinical or behavioral research study. It defines eligibility criteria, procedures, data collection instruments, safety monitoring, and roles and responsibilities for investigators and staff. The protocol guides Institutional Review Board (IRB) review, informed consent processes, and regulatory submissions, and for multi-site projects it ensures consistent implementation, training, and quality assurance across participating sites and oversight committees.

Why a Clear Protocol Matters for Compliance and Quality

A complete Research Study Protocol reduces regulatory risk, supports reproducible results, facilitates IRB approval, and documents participant protections. It establishes roles, timelines, and data handling rules necessary to meet federal standards such as the Common Rule and HIPAA and to satisfy sponsor and auditor expectations.

Typical Users and Stakeholders

The Research Study Protocol is used by clinical and research teams, institutional reviewers, sponsors, and operational staff who must implement, review, or audit the study.

Principal investigators responsible for protocol design, oversight, and compliance monitoring
Clinical research coordinators who implement procedures, enroll participants, and document data
Sponsors, safety monitors, statisticians, and regulatory affairs personnel reviewing study integrity

Access and responsibilities vary by role; ensure each stakeholder receives the approved protocol version and any site-specific appendices before study activities begin.

Core Components Found in a Professional Research Study Protocol

Primary components of a professional Research Study Protocol describe study rationale, recruitment, methods, safety oversight, statistical plans, data management, and site responsibilities to drive consistent conduct across locations.

Study Overview

Summarize objectives, hypotheses, target population, and primary/secondary endpoints. Provide background justification and references supporting the study rationale and relevance to the field.

Eligibility Criteria

List inclusion and exclusion criteria with clear rationale, screening procedures, and any enrollment limits or stratification factors affecting participant selection.

Methods & Procedures

Detail visit schedule, interventions, sample collection, randomization, blinding, data collection instruments, and handling of protocol deviations to ensure consistent execution.

Safety Monitoring

Define adverse event reporting, stopping rules, Data Safety Monitoring Board involvement (if applicable), safety surveillance, and responsibilities for prompt reporting to IRB and sponsor.

Statistical Plan

Specify sample size calculations, primary analysis populations, statistical methods, interim analyses, missing data handling, and multiplicity adjustments.

Data Management

Describe data capture systems, source documents, coding conventions, quality assurance processes, retention schedules, and procedures for data access and confidentiality.

Step-by-Step: From Draft to Approved Protocol

Follow a structured review and approval workflow to minimize revisions and support timely IRB submission and site activation.

01

Draft Protocol: Assemble rationale, methods, consent form, and appendices for initial draft.
02

Internal Review: Circulate the draft to team members, sponsors, and legal for feedback and revisions.
03

IRB Submission: Submit the protocol package to the IRB with supporting documents and required disclosures.
04

Finalize & Archive: Publish the approved version, notify sites, and secure permanent records with version control.

Where Protocols Are Sent and How They Are Routed

Identify the destination for each approved document—IRB, sponsor, regulatory agencies, and participating sites—and follow institutional routing rules.

To IRB: Submit via institutional eIRB system or paper packet following local templates and checklists.
To Sponsor: Provide sponsor package and obtain confirmation of protocol receipt and approval conditions.
Regulatory Agencies: File safety reports or IND-related notices to FDA and other authorities when required.
Study Sites: Distribute final protocol and site-specific appendices to participating centers for implementation.

Digital Workflow Settings for Online Completion and Distribution

Configure the eSignature and document workflow to enforce identity, version control, and an auditable trail for protocol approvals.

Field	Configuration
eSignature Platform	signNow with API, templates, and audit trail enabled for document control
Authentication	Email link, SMS code, or institution SSO for signer verification
Templates	Pre-fill protocol sections and use conditional fields for site-specific appendices
Version Control	Enforce version lock, retain amendment history, and prevent older-version signing

Technical and Security Requirements for eSubmission

Online completion requires compatible formats, signer authentication, secure transport, and an audit-capable eSignature provider with appropriate compliance controls.

File Formats: PDF and DOCX; prefer locked PDF for final versions
Integrations: Salesforce, Microsoft 365, NetSuite supported for document routing
Security: TLS 1.2/1.3 in transit and AES-256 at rest

Comparing eSignature Vendor Pricing and Compliance Features

Vendor pricing and feature availability relevant to protocol e-signing and compliance; signNow appears first per comparison conventions in vendor overviews.

	signNow	DocuSign	Adobe Sign	PandaDoc	HelloSign
Starting Price	$8/user/mo	$15/user/mo	$14/user/mo	$19/user/mo	$15/user/mo
Free Trial	7-day free trial	Varies by vendor	Varies by vendor	Varies by vendor	Varies by vendor
Bulk Send	Yes	Yes	Yes	Yes	No
Audit Trail	Yes	Yes	Yes	Yes	Yes
HIPAA Compliant	Yes	Yes	Yes	No	No
Envelope Cap	No envelope cap	100 envelopes/user/year	Varies by plan	Varies by plan	Varies by plan

Key Milestones from Drafting to Site Activation

A milestone sequence helps track responsibilities and approval gates from initial draft through site activation and ongoing compliance monitoring.

01

Draft Completion

Assemble full protocol and attachments for initial review and stakeholder input.

02

IRB Submission

Submit required documents and respond to IRB queries until approval.

03

Approval & Signature

Obtain final approvals, collect required signatures, and lock the approved version.

04

Site Activation

Distribute protocol to sites, train staff, and confirm readiness to enroll participants.

Typical Review and Processing Timeframes to Expect

Use typical time ranges to plan project timelines, remembering that institution, sponsor, and regulatory complexity affect actual durations.

Initial IRB Full Review:

Often 30–60 days depending on board schedule and submission completeness

Expedited IRB Review:

Commonly 7–21 days for eligible minimal-risk submissions

Sponsor Review:

Typically 2–4 weeks for sponsor legal and operational review

Site Training and Setup:

Allow 1–2 weeks for site training and documentation distribution

Amendment Processing:

Plan for 2–8 weeks depending on amendment scope and IRB workload

Practical Examples of Protocol Adoption and Results

Real-world examples illustrate how standardized protocols and digital signing reduce administrative bottlenecks and improve audit readiness.

Optica Ventures

Optica Ventures used a standardized Research Study Protocol template to streamline enrollment across portfolio companies and ensure consistent regulatory language.

Reduced administrative delays by centralizing documents and approvals across sites.
Brian Fitzgibbons, COO, said "The interface is simple and easy-to-use for our team; more importantly, it is just as easy for our customers." The result was faster IRB-ready submissions and more consistent recordkeeping.

Fertility Centers

A clinical practice standardized consent and protocol annexes to reduce version mismatch during multisite studies.

Improved turnaround and record consistency across clinics.
John Butler, Founder of Fertility Centers of Illinois, reported that the solution provided responsive support and flexible integration, helping maintain compliance while accelerating protocol sign-off and execution.

Practical Tips to Complete a Research Study Protocol Accurately

Adopt consistent practices and controls to reduce errors, speed approvals, and strengthen compliance posture across sites.

Standardize Protocol Templates Across Sites

Use a single master protocol with site-specific appendices to reduce inconsistencies. Maintain a controlled template in your document management system and require formal amendments for changes.

Use Robust Version Control and Audit Trails

Lock approved versions, log all changes, and preserve signatures and timestamps to simplify audits and prevent unauthorized edits or use of obsolete documents.

Define Clear Safety Reporting Responsibilities

Specify adverse event grading, reporting timelines, and the sponsor's safety contact in the protocol to ensure timely regulatory and IRB notifications.

Validate Data Management and Confidentiality Measures

Document data capture systems, access controls, encryption, and retention policies. Confirm HIPAA, FERPA, and state privacy obligations are addressed where relevant.

Common Mistakes to Avoid When Preparing a Protocol

Vague inclusion or exclusion criteria that allow inconsistent enrollment across sites, complicating pooled analyses and increasing protocol violations during monitoring visits.
Incomplete or unclear visit schedules and procedures that force on-the-fly decisions, increasing protocol deviations and data inconsistency across centers.
Failure to define adverse event grading or reporting timelines, leading to underreporting and delayed safety signal management during reviews.
Poor version control on consent forms and CRFs, causing mismatched records, protocol drift, and regulatory audit findings.

Essential Data Elements to Include in the Protocol

Protocol Title: Official study title and short identifier

Sponsor: Legal entity funding the study

Principal Investigator: Name, degrees, and contact details

IRB Approval: Board name and approval date

Version Number: Protocol iteration and effective date

Key Attachments: Consent form, CRFs, SOPs, and appendices

Consequences of an Incorrect or Incomplete Protocol

IRB Noncompliance: Suspension or termination of study

Data Breach: HIPAA violations, fines, corrective plans

Participant Harm: Increased liability and mandatory reporting

Funding Risk: Sponsor withdrawal or audit findings

Regulatory Sanctions: FDA inspection consequences possible

Publication Retraction: Invalidated results and reputational harm

Representative Roles and Responsibilities

Dr. Maria Lopez, Principal Investigator

Leads study design, approves final protocol language, and is accountable for participant safety, data integrity, and compliance. The PI coordinates with sponsors, IRBs, and site investigators and signs the protocol or delegation log as required.

Clinical Research Coordinator

Implements procedures, completes source documentation, manages informed consent logistics, and communicates with monitoring and sponsor teams to ensure protocol adherence and accurate data capture.

Frequently Asked Questions About Research Study Protocols

Answers address common questions about legal validity, e-signatures, submission routes, and retention to help teams avoid delays and compliance issues.

Need help? Contact support

Can a protocol be signed electronically?
Yes. Electronic signatures are legally valid under the ESIGN Act (15 U.S.C. §7001) and UETA where adopted. Confirm any institutional or sponsor requirements for signer authentication and retainable audit trails to demonstrate intent and attribution.
Do patient consent forms require special disclosures?
Yes. For consumer-facing health documents, include an ESIGN consumer disclosure where required and ensure consent language meets HIPAA and IRB requirements for use and sharing of protected health information.
When is notarization required for protocol documents?
Notarization is rarely required for the protocol itself but may be required for certain legal agreements or authorization forms. Check institutional policies and state notary rules if a signature acknowledgement is requested.
How long must protocol records be retained?
Retention depends on regulatory and sponsor requirements: IRS records generally 3 years (IRC §6501(a)), HIPAA 6 years (45 CFR §164.530(j)), and some financial or SEC-related records longer. Follow sponsor and institutional policies.
What causes IRB review delays?
Common causes include incomplete documentation, unclear eligibility criteria, missing consent forms, inadequate safety monitoring plans, and inconsistent versioning. Address these items before submission to reduce turnaround time.
Can remote online notarization (RON) be used?
Many states permit RON, but rules vary. Verify state-specific RON availability and institutional acceptance, and retain required audio-video records and identity proofing per the state's notary standards.

be ready to get more

Join over 28 million airSlate SignNow users

Sign Now